1. Home
  2. QUAD vs CMPX Comparison

QUAD vs CMPX Comparison

Compare QUAD & CMPX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • QUAD
  • CMPX
  • Stock Information
  • Founded
  • QUAD 1971
  • CMPX 2014
  • Country
  • QUAD United States
  • CMPX United States
  • Employees
  • QUAD N/A
  • CMPX N/A
  • Industry
  • QUAD Publishing
  • CMPX Biotechnology: Pharmaceutical Preparations
  • Sector
  • QUAD Consumer Discretionary
  • CMPX Health Care
  • Exchange
  • QUAD Nasdaq
  • CMPX Nasdaq
  • Market Cap
  • QUAD 300.1M
  • CMPX 229.5M
  • IPO Year
  • QUAD 2010
  • CMPX N/A
  • Fundamental
  • Price
  • QUAD $5.83
  • CMPX $2.10
  • Analyst Decision
  • QUAD Strong Buy
  • CMPX Strong Buy
  • Analyst Count
  • QUAD 2
  • CMPX 8
  • Target Price
  • QUAD $9.45
  • CMPX $13.13
  • AVG Volume (30 Days)
  • QUAD 364.5K
  • CMPX 804.2K
  • Earning Date
  • QUAD 07-29-2025
  • CMPX 05-08-2025
  • Dividend Yield
  • QUAD 5.15%
  • CMPX N/A
  • EPS Growth
  • QUAD N/A
  • CMPX N/A
  • EPS
  • QUAD N/A
  • CMPX N/A
  • Revenue
  • QUAD $2,646,800,000.00
  • CMPX $850,000.00
  • Revenue This Year
  • QUAD N/A
  • CMPX N/A
  • Revenue Next Year
  • QUAD N/A
  • CMPX N/A
  • P/E Ratio
  • QUAD N/A
  • CMPX N/A
  • Revenue Growth
  • QUAD N/A
  • CMPX N/A
  • 52 Week Low
  • QUAD $4.06
  • CMPX $0.77
  • 52 Week High
  • QUAD $9.13
  • CMPX $4.08
  • Technical
  • Relative Strength Index (RSI)
  • QUAD 55.33
  • CMPX 56.95
  • Support Level
  • QUAD $5.12
  • CMPX $2.02
  • Resistance Level
  • QUAD $6.10
  • CMPX $2.23
  • Average True Range (ATR)
  • QUAD 0.25
  • CMPX 0.12
  • MACD
  • QUAD 0.01
  • CMPX 0.02
  • Stochastic Oscillator
  • QUAD 71.00
  • CMPX 66.67

About QUAD Quad Graphics Inc

Quad/Graphics Inc provides print and marketing services to help customers market their products, services, and contents. The company operates in the commercial segment of the printing industry. It operates through three divisions. The United States print and related services segment consists of the company's American operations. Besides the complete set of print and marketing solutions, this segment also manufactures ink. The international segment includes the company's printing business in Europe and Latin America and others countries. The corporate segment is engaged in the general and administrative activities as well as associated costs. The company almost generates all its revenue from the American domestic market..

About CMPX Compass Therapeutics Inc.

Compass Therapeutics Inc is a clinical-stage biopharmaceutical company that develops proprietary antibody therapeutics to engage the immune system to treat solid tumors and hematological malignancies. It is engaged in drug discovery by leveraging its proprietary antibody discovery engine to drug the immune system and identify optimal combinations empirically broadly. Through StitchMabs and common light chain platforms, these combinatorial insights can be rapidly translated into tailored bispecifics with monoclonal-like manufacturability. Its pipeline is comprised of the following product candidates; CTX-009, CTX-471, CTX-10726, VEGF-IO Bispecific, and CTX-8371.

Share on Social Networks: